An even stronger interaction, which has already been therapeutically exploited, occurs between the human agt-1 ortholog MGMT and temozolomide, a DNA alkylating chemotherapeutic, in temozolomide-treated glioblastomas (Fig. 3d)34. This evidence concerns the gene MGMT and glioblastoma.